Daya_Res
Please reply to this response with a minimum of two paragraphs, two references no less than 5 years old, no plagiarism.
Urinary tract infections commonly abbreviated as U.T.I are infections that are known to attack the urinary tract. U.T.I can attack either the lower urinary tract or the upper urinary tract or both. Attack of the lower urinary tract is always referred to as bladder infection whereas lower urinary track is always referred to as kidney infection.(Bonadio & Maida, 2014).
According to Tängdén and Giske, (2015), use of single drug to treat U.T.I can be disadvantageous in that single drug use can promote development of dangerous antibiotic resistant bacteria. For instance the single drug used might not be that effective in all parts of the infected urinary parts hence instead of killing the bacteria, they make them bacteria stronger.
Single drug prescription can also be disadvantageous in treating Urinary tract infection in that there might be more than one bacterial infection in the same urinary track. The single drug would only kill the bacteria it’s meant for and not kill other bacteria it’s not meant to eliminate. The results of such scenarios are further development of bacteria on the urinary track that would only threaten the patient’s life. (Brust, Evans, & Plemmons, 2014).
On the other hand single drug prescription can be advantageous in treating of urinary track infection. According to Huttner et. al, (2015).Most single drugs meant for urinary tract infection can treat several bacteria. For instance nitrofurantoin drug has the strength of acting on multiple sites and levels including inhibition of several bacterial enzymes on the urinary track. Single drug prescription for treatment of urinary tract infection is also advantageous in that there’s reduced severity of side effects of single drugs as compared to multiple drug prescription. When side effects become severe, the doctor has the responsibility of prescribing another drug with less severe side effects. This can only be achieved when a single drug is first prescribed and results on the patient determine the next t course of prescription.
References
Bonadio, W., & Maida, G. (2014). Urinary tract infection in outpatient febrile infants younger than 30 days of age: a 10-year evaluation. The Pediatric infectious disease journal, 33(4), 342-344.
Brust, K., Evans, A., & Plemmons, R. (2014). Tigecycline in treatment of multidrug-resistant Gram-negative bacillus urinary tract infections: a systematic review. Journal of Antimicrobial Chemotherapy, 69(10), 2606-2610.
Huttner, A., Verhaegh, E. M., Harbarth, S., Muller, A. E., Theuretzbacher, U., & Mouton, J. W. (2015). Nitrofurantoin revisited: a systematic review and meta-analysis of controlled trials. Journal of Antimicrobial Chemotherapy, 70(9), 2456-2464.